mPharma
Signal active
Organization
Contact Information
Overview
mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. It aims to increase patient access to high-quality medications. mPharma partners with drug manufacturers, insurance companies, financial institutions, and governments to deliver prescription drugs directly to consumers in emerging markets. They provide doctors, patients, and pharmacists access to a network of high-quality chronic disease medicine at sustainable prices.
The company was founded by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) in 2013.
About
Industries
Health Care, Pharmaceutical, Hospital
Founded
2013
Employees
1001-5000
Headquarters locations
Africa
Social
N/A
Profile Resume
mPharma headquartered in Africa, operates in the Health Care, Pharmaceutical, Hospital sector. The company focuses on Health Care and has secured $15.1B in funding across 168 round(s). With a team of 1001-5000 employees, mPharma is actively contributing to advancements in Health Care. Their latest funding round, Pre Seed Round - mPharma, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
14
Investors
1
Lead Investors
0
Total Funding Amount
$89.8M
Details
9
mPharma has raised a total of $89.8M in funding over 9 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2015 | Seed | |||
| 2022 | Late Stage Venture | 30.0M | ||
| 2016 | Seed | 5.0M | ||
| 2014 | Seed |
Investors
mPharma is funded by 66 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| mPharma | - | FUNDING ROUND - mPharma | 5.0M |
| Peregrine Ventures | - | FUNDING ROUND - Peregrine Ventures | 5.0M |
| mPharma | - | FUNDING ROUND - mPharma | undefined |
| Microsoft Accelerator | - | FUNDING ROUND - Microsoft Accelerator | undefined |
Recent Activity
There is no recent news or activity for this profile.